← Back
Data updated: Mar 10, 2026
HALEON US HOLDINGS
Gastroenterology
HALEON US HOLDINGS is a specialty pharmaceutical company focused on Gastroenterology. Key products include ADVIL ALLERGY AND CONGESTION RELIEF.
1984
Since
28
Drugs
-
Trials
16
Approved (2yr)
Key Drugs
Recent Activity
FLONASE ALLERGY RELIEF 2025-12-19
Labeling
FLONASE SENSIMIST ALLERGY RELIEF 2025-12-19
Labeling
FLONASE SENSIMIST ALLERGY RELIEF 2025-09-15
Labeling
ADVIL DUAL ACTION WITH ACETAMINOPHEN 2025-05-05
Labeling
NICORETTE 2025-03-17
Manufacturing (CMC)
FLONASE ALLERGY RELIEF 2025-01-10
Labeling
FLONASE SENSIMIST ALLERGY RELIEF 2025-01-10
Labeling
ADVIL LIQUI-GELS 2025-01-08
Labeling
ADVIL 2024-12-30
Labeling
NICORETTE 2024-11-21
Manufacturing (CMC)
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Gastroenterology 100%
0 drugs Phase 1: 1
Pipeline Strength Pro
Loading...
Active (24)
ADVIL DUAL ACTION WITH ACETAMINOPHEN FLONASE ALLERGY RELIEF ADVIL ALLERGY AND CONGESTION RELIEF ADVIL MULTI-SYMPTOM COLD & FLU ADVIL CONGESTION RELIEF VOLTAREN ARTHRITIS PAIN FLONASE SENSIMIST ALLERGY RELIEF ALLI ADVIL PM CHILDREN'S ADVIL ALLERGY SINUS ADVIL ALLERGY SINUS CHILDREN'S ADVIL COLD ABREVA INFANT'S ADVIL EXCEDRIN (MIGRAINE RELIEF) JUNIOR STRENGTH ADVIL CHILDREN'S ADVIL-FLAVORED AXID AR ADVIL LIQUI-GELS ADVIL MIGRAINE LIQUI-GELS ADVIL COLD AND SINUS ADVIL NICORETTE NICORETTE (MINT)
Discontinued (4)
Company Info
- First Approval
- 1984-01-13
- Latest
- 2025-12-19
- Applications
- 31